Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001441449-26-000014·Autolus Therapeutics plc
Schedule 13G ownership disclosure
AUTOLUS THERAPEUTICS LTD
Depositary Receipt S ADR · CUSIP: 05280R100
Event date: 2026-09-30
- Filing-level shares
- 9,184,404.00
- Percent of class
- 3.5%
- Qatar Investment Authority
Shares: 9,184,404.00 · Class: 3.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001441449-26-000014
- Form type
- SCHEDULE 13G/A
- Filer
- Autolus Therapeutics plc
- CIK
- CIK 1730463
- Filed
- Nov 12, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership